
Vivek Anant Karve
About Vivek Anant Karve
Data last updated:
Vivek Anant Karve is a Director at Eternis Fine Chemicals Limited (since 2025), Director at Suryoday Small Finance Bank Limited (since 2025) and Director at Kaya Limited (since 2025), and holds 4 more current directorships. The companies operate in Chemicals and Materials, Financial Services and E-Commerce. The 4 current companies with reported revenue have a combined latest revenue of ₹5,352 Cr; the largest is Eternis Fine Chemicals Limited at ₹2,598 Cr (FY 2026). Earlier, Vivek Anant Karve was a Director at Mahindra Rural Housing Finance Limited (2021–2024) and Director at Mahindra Insurance Brokers Limited (2021–2024) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 Feb 2025 | 1965 | ₹2,598 Cr (FY 2026) | Active | |
| Director | 21 Jan 2025 | 2008 | ₹2,520 Cr (FY 2026) | Active | |
| Director | 01 Apr 2025 | 2003 | ₹234 Cr (FY 2025) | Active | |
| Director | 21 Mar 2018 | 2018 | ₹1,660 (FY 2025) | Active | |
| Director | 15 Sep 2025 | 2008 | Active | ||
| Director | 23 Jun 2026 | 2011 | Active | ||
| Director | 11 Apr 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Jul 2021 | 2007 | ₹1,350 Cr (FY 2023) | Active | |
| Director | 05 Jan 2021 | 1987 | ₹1,095 Cr (FY 2024) | Active | |
| Director | 06 Oct 2022 | 2019 | ₹2.3 Lakh (FY 2026) | Active | |
| Cfo | 14 Sep 2020 | 1991 | ₹18,530 Cr (FY 2025) | Active | |
| Cfo | 12 Mar 2014 | 2012 | ₹6.77 Cr (FY 2020) | Amalgamated | |
| Cfo | 01 Apr 2014 | 1988 | ₹13,815 Cr (FY 2026) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vivek Anant Karve
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vivek Anant Karve
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivek Anant Karve
Vivek Anant Karve currently holds 7 directorships: Eternis Fine Chemicals Limited (Director, since 14 Feb 2025, revenue ₹2,598 Cr (FY 2026)); Suryoday Small Finance Bank Limited (Director, since 21 Jan 2025, revenue ₹2,520 Cr (FY 2026)); Kaya Limited (Director, since 01 Apr 2025, revenue ₹234 Cr (FY 2025)); Process Intelligence And Dynamics Private Limited (Director, since 21 Mar 2018, revenue ₹1,660 (FY 2025)); Niva Bupa Health Insurance Company Limited (Director, since 15 Sep 2025); and 2 more.
Vivek Anant Karve was first appointed on 12 Mar 2014 as Cfo at Marico Consumer Care Limited. The most recent appointment on record is 23 Jun 2026 at Aavas Financiers Limited.
The 4 current companies of Vivek Anant Karve that report revenue have a combined latest revenue of ₹5,352 Cr: Eternis Fine Chemicals Limited ₹2,598 Cr (FY 2026); Suryoday Small Finance Bank Limited ₹2,520 Cr (FY 2026); Kaya Limited ₹234 Cr (FY 2025); Process Intelligence And Dynamics Private Limited ₹1,660 (FY 2025).
Vivek Anant Karve held 6 earlier board appointments: Mahindra Rural Housing Finance Limited (Director, 17 Jul 2021 to 31 Oct 2024); Mahindra Insurance Brokers Limited (Director, 05 Jan 2021 to 31 Oct 2024); Mahindra Finance Csr Foundation (Director, 06 Oct 2022 to 31 Oct 2024); Mahindra And Mahindra Financial Services Limited (Cfo, 14 Sep 2020 to 31 Oct 2024); Marico Consumer Care Limited (Cfo, 12 Mar 2014 to 10 Sep 2020); and 1 more.
The current boards of Vivek Anant Karve's companies include Achim Gerhard Daub (Eternis Fine Chemicals Limited), Anita Belani (Eternis Fine Chemicals Limited), Chetan Dinesh Chowatia (Eternis Fine Chemicals Limited), Harsh Charandas Mariwala (Eternis Fine Chemicals Limited), Ketan Arvind Dalal (Eternis Fine Chemicals Limited), Rajendra Kishore Mariwala (Eternis Fine Chemicals Limited), among others.